Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1α pathway
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Branched-chain amino acids (BCAAs), particularly leucine, are indispensable AAs for immune regulation through metabolic rewiring. However, the molecular mechanism underlying this phenomenon remains unclear. Our investigation revealed that T-cell receptor (TCR)-activated human CD4+ T cells increase the expression of BCAT1, a cytosolic enzyme responsible for BCAA catabolism, and SLC7A5, a major BCAA transporter. This upregulation facilitates increased leucine influx and catabolism, which are particularly crucial for Th17 responses. Activated CD4+ T cells induce an alternative pathway of cytosolic leucine catabolism, generating a pivotal metabolite, β-hydroxy β-methylbutyric acid (HMB), by acting on BCAT1 and 4-hydroxyphenylpyruvate dioxygenase (HPD)/HPD-like protein (HPDL). Inhibition of BCAT1-mediated cytosolic leucine metabolism, either with BCAT1 inhibitor 2 (Bi2) or through BCAT1, HPD, or HPDL silencing using shRNA, attenuates IL-17 production, whereas HMB supplementation abrogates this effect. Mechanistically, HMB contributes to the regulation of the mTORC1-HIF1α pathway, a major signaling pathway for IL-17 production, by increasing the mRNA expression of HIF1α. This finding was corroborated by the observation that treatment with L-β-homoleucine (LβhL), a leucine analog and competitive inhibitor of BCAT1, decreased IL-17 production by TCR-activated CD4+ T cells. In an in vivo experimental autoimmune encephalomyelitis (EAE) model, blockade of BCAT1-mediated leucine catabolism, either through a BCAT1 inhibitor or LβhL treatment, mitigated EAE severity by decreasing HIF1α expression and IL-17 production in spinal cord mononuclear cells. Our findings elucidate the role of BCAT1-mediated cytoplasmic leucine catabolism in modulating IL-17 production via HMB-mediated regulation of mTORC1-HIF1α, providing insights into its relevance to inflammatory conditions.
Abstract
Branched-chain amino acids (BCAAs), particularly leucine, are indispensable AAs for immune regulation through metabolic rewiring. However, the molecular mechanism underlying this phenomenon remains unclear. Our investigation revealed that T-cell receptor (TCR)-activated human CD4+ T cells increase the expression of BCAT1, a cytosolic enzyme responsible for BCAA catabolism, and SLC7A5, a major BCAA transporter. This upregulation facilitates increased leucine influx and catabolism, which are particularly crucial for Th17 responses. Activated CD4+ T cells induce an alternative pathway of cytosolic leucine catabolism, generating a pivotal metabolite, β-hydroxy β-methylbutyric acid (HMB), by acting on BCAT1 and 4-hydroxyphenylpyruvate dioxygenase (HPD)/HPD-like protein (HPDL). Inhibition of BCAT1-mediated cytosolic leucine metabolism, either with BCAT1 inhibitor 2 (Bi2) or through BCAT1, HPD, or HPDL silencing using shRNA, attenuates IL-17 production, whereas HMB supplementation abrogates this effect. Mechanistically, HMB contributes to the regulation of the mTORC1-HIF1α pathway, a major signaling pathway for IL-17 production, by increasing the mRNA expression of HIF1α. This finding was corroborated by the observation that treatment with L-β-homoleucine (LβhL), a leucine analog and competitive inhibitor of BCAT1, decreased IL-17 production by TCR-activated CD4+ T cells. In an in vivo experimental autoimmune encephalomyelitis (EAE) model, blockade of BCAT1-mediated leucine catabolism, either through a BCAT1 inhibitor or LβhL treatment, mitigated EAE severity by decreasing HIF1α expression and IL-17 production in spinal cord mononuclear cells. Our findings elucidate the role of BCAT1-mediated cytoplasmic leucine catabolism in modulating IL-17 production via HMB-mediated regulation of mTORC1-HIF1α, providing insights into its relevance to inflammatory conditions.
참고문헌 (56)
- Teng, X., "Immune cell metabolism in autoimmunity", Clin. Exp. Immunol, 197, pp.181~192 (2019)
- MacIver, N. J., "Metabolic regulation of T lym phocytes", Annu. Rev. Immunol, 31, pp.259~283 (2013)
- Hayashi, K., "LAT1 is a critical trans porter of essential amino acids for immune reactions in activated human T cells", J. Immunol, 191, pp.4080~4085 (2013)
- Vaeth, M., "Store-operated Ca(2+) entry controls clonal expansion of T cells through metabolic reprogramming", Immunity, 47, pp.664~679 (2017)
- O’Neill, L. A., "A guide to immunometabolism for immunologists", Nat. Rev. Immunol, 16, pp.553~565 (2016)
- Nakaya, M., "Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation", Immunity, 40, pp.692~705 (2014)
- Sinclair, L. V., "Control of amino-acid transport by antigen receptors coordi nates the metabolic reprogramming essential for T cell differentiation", Nat. Immunol, 14, pp.500~508 (2013)
- Cibrian, D., "Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation", J. Allergy Clin. Immunol, 145, pp.199~214 (2020)
- amino acid metabolism: implications for establishing safe intakes, "J. Nutr", 2005, 1557S~1564S
- Endo, K., "Procyanidin B2 gallate regulates TNF-alpha production from T cells through inhibiting glycolytic activity via mTOR-HIF-1 pathway", Biochem Pharm, 177, pp.113952~ (2020)
- Duvel, K., "Activation of a metabolic gene regulatory network downstream of mTOR complex 1", Mol. Cell, 39, pp.171~183 (2010)
- Ananieva, E. A., "Cytosolic branched chain aminotransferase(BCATc)regulates mTORC1 signaling and gly colytic metabolism in CD4+ T cells", J. Biol. Chem, 289, pp.18793~18804 (2014)
- Suh, E. H., "In vivo assessment of increased oxidation of branched-chain amino acids in glioblastoma", Sci. Rep, 9, pp.340~ (2019)
- Sweatt, A. J., "Branched-chain amino acid catabolism : unique segregation of pathway enzymes in organ systems and peripheral nerves", Am. J. Physiol. Endo crinol. Metab, 286, pp.E64~E76 (2004)
- Yoon, B. R., "Role of SLC7A5 in metabolic reprogramming of human monocyte", macrophage immune responses, 2018, pp.9, 53~
- Papathanassiu, A. E., "BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases", Nat. Com mun, 8, pp.16040~ (2017)
- Lee, G. H., "Anti-thymocyte globulin-mediated immunosenescent alterations of T cells in kidney transplant patients", Clin. Transl. Immunol, 11, pp.e1431~ (2022)
- Zhang, Y., "Determination of branched-chain keto acids in serum and muscles using high performance liquid chromatography-quadrupole time-of-flight mass spectrometry", Molecules, 23, pp.147~ (2018)
- Gutierrez-Arcelus, M., "Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci", Nat. Genet, 52, pp.247~253 (2020)
- Caballero, J., "Docking and quantitative structure-activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase", Mol. Divers, 13, pp.493~500 (2009)
- Luo, L., "BCAT1 decreases the sensitivity of cancer cells to cisplatin by reg ulating mTOR-mediated autophagy via branched-chain amino acid metabolism", Cell Death Dis, 12, pp.169~ (2021)
- Saxton, R. A., "Structural basis for leucine sensing by the Sestrin2-mTORC1pathway", Science, 351, pp.53~58 (2016)
- Xu, Y., "Ghrelin inhibits the differentiation of T helper 17 cells through mTOR", STAT3 signaling pathway, 2015, pp.10, e0117081~
- Ghosh, S. G., "Biallelic variants in HPDL, encoding 4-hydroxyphenylpyruvate dioxygenase-like protein, lead to an infantile neurodegenerative condition", Genet Med, 23, pp.524~533 (2021)
- Van Koevering, M., "Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo", Am. J. Physiol, 262, pp.E27~E31 (1992)
- Portal, S., "Effect of HMB supple mentation on body composition, fitness, hormonal profile and muscle damage indices", J. Pediatr. Endocrinol. Metab, 23, pp.641~650 (2010)
- Zhang, X., "Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lympho cytes", J. Immunol, 180, pp.6988~6996 (2008)
- Soriano-Baguet, L., "Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions", Cell Rep, 42, pp.112153~ (2023)
- Frost, J., "Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition", Nat. Commun, 7, pp.13312~ (2016)
- Keith, B., "HIF1alpha and HIF2alpha : sibling rivalry in hypoxic tumour growth and progression", Nat. Rev. Cancer, 12, pp.9~22 (2011)
- Dodd, K. M., "mTORC1 drives HIF 1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1and STAT3", Oncogene, 34, pp.2239~2250 (2015)
- Dang, E. V., "Control of T(H)17", T(reg)balance by hypoxia-inducible factor 1, 2011, pp.146, 772~784
- Serada, S., "IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis", Proc. Natl Acad. Sci. USA, 105, pp.9041~9046 (2008)
- Kanai, Y., "Amino acid transporter LAT1(SLC7A5)as a molecular target for cancer diagnosis and therapeutics", Pharm. Ther, 230, pp.107964~ (2022)
- Nagamori, S., "Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling", Amino Acids, 48, pp.1045~1058 (2016)
- Lelais, G., "Beta2-amino acids-syntheses, occurrence in natural products, and components of beta-peptides1, 2", Biopolymers, 76, pp.206~243 (2004)
- Calder, P. C., "Branched-chain amino acids and immunity", J. Nutr, 136, pp.288S~293S (2006)
- Ikeda, K., "Slc3a2 mediates branched-chain amino-acid-dependent main tenance of regulatory T cells", Cell Rep, 21, pp.1824~1838 (2017)
- Yao, C. C., "Accumulation of branched-chain amino acids reprograms glucose metabolism in CD8(+)T cells with enhanced effector function and anti-tumor response", Cell Rep, 42, pp.112186~ (2023)
- Neinast, M. D., "Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids", Cell Metab, 29, pp.417~429 (2019)
- Ananieva, E. A., "Branched-chain amino acid metabolism in cancer", Curr. Opin. Clin. Nutr. Metab. Care, 21, pp.64~70 (2018)
- Newgard, C. B., "A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance", Cell Metab, 9, pp.311~326 (2009)
- Mann, G., "Branched-chain amino acids:catabolism in skeletal muscle and implications for muscle and whole-body metabolism", Front Physiol, 12, pp.702826~ (2021)
- Wolfson, R. L., "Sestrin2 is a leucine sensor for the mTORC1 pathway", Science, 351, pp.43~48 (2016)
- Ananieva, E. A., "Leucine metabolism in T cell acti vation: mTOR signaling and beyond", Adv. Nutr, 7, pp.798S~805S (2016)
- Sivanand, S., "Emerging roles for branched-chain amino acid metabolism in cancer", Cancer Cell, 37, pp.147~156 (2020)
- Holecek, M., "Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions", J. Cachexia Sarcopenia Muscle, 8, pp.529~541 (2017)
- Giron, M. D., "Conversion of leucine to beta-hydroxy-beta-methylbutyrate by alpha-keto isocaproate dioxygenase is required for a potent stimulation of pro tein synthesis in L6 rat myotubes", J. Cachexia Sarcopenia Muscle, 7, pp.68~78 (2016)
- Duan, Y., "The role of leucine and its metabolites in protein and energy metabolism", Amino Acids, 48, pp.41~51 (2016)
- Suryawan, A., "Differential regulation of mTORC1 activation by leucine and beta-hydroxy-beta-methylbutyrate in skeletal muscle of neonatal pigs", J. Appl. Physiol, 128, pp.286~295 (2020)
- Hu, X., "Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists", Nat. Chem. Biol, 11, pp.141~147 (2015)
- Pietrocola, F., "Acetyl coenzyme A: a central metabolite and second messenger", Cell Metab, 21, pp.805~821 (2015)
- Hochrein, S. M., "The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming", Cell Metab, 34, pp.516~532 (2022)
- Vukovich, M. D., "beta-hydroxy-beta-methylbutyrate(HMB)kinetics and the influence of glucose ingestion in humans", J. Nutr. Biochem, 12, pp.631~639 (2001)
- "BCAT1 inhibition affects CD8+ T cell activation, exhaustion, and tumoral immunity by altering iron homeostasis" (2023)[URL]
- Corcoran, S. E., "HIF1alpha and metabolic reprogramming in inflammation", J. Clin. Invest, 126, pp.3699~3707 (2016)